Breyanzi (lisocabtagene maraleucel) - BMS
Kymriah (tisagenlecleucel-T) - Novartis
Epkinly (epcoritamab-bysp) - Genmab, AbbVie
Yescarta (axicabtagene ciloleucel) - Gilead
https://www.sciencedirect.com/science/article/abs/pii/S2152265026026649
 
Laiba Manzoor 1; Faiza Khalid 2; Ashesh Das 3
 
Sep 1, 2026
 
Prev Next